Hosted on MSN40m
What To Expect From Myriad Genetics’s (MYGN) Q4 EarningsGenetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results tomorrow after market hours. Here’s what you need to know. Myriad Genetics beat analysts’ revenue expectations by 1.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback